Biden Budget Boosts Domestic HIV Funding & Proposes PrEP and Hepatitis C Programs

HIV+Hep praises President Biden’s FY24 proposed budget for significantly increasing federal funding to end HIV and hepatitis C in the US. Now it is up to Congress to deliver.
See the press release

HIV Organizations File Discrimination Complaints Against North Carolina Blue Cross Blue Shield

HIV+Hep & NCAAN filed ACA discrimination complaints against North Carolina Blue Cross/Blue Shield for placing almost all HIV drugs, including generics like PrEP, on the highest drug tiers. The complaints were filed with the North Carolina Department of Insurance and the US HHS Office of Civil Rights.
See the press release

HIV+Hep releases report detailing funding needed to increase PrEP uptake

The HIV+Hepatitis Policy Institute has released a report modeling the resources needed to fund a national PrEP program to cover the cost of medications, associated labs, and prescriber time for the uninsured along with necessary provider and community outreach to increase uptake, estimating the cost at $521 million for the first year and $6.18 billion over ten years.
See the press release

Patient groups file suit to end policy that prohibits copay assistance from counting toward patients' out-of-pocket spending

The HIV+Hepatitis Policy Insite, the Diabetes Leadership Council, and the Diabetes Patient Advocacy Coalition filed suit in the U.S. District Court for the District of Columbia challenging a federal rule that allows health insurers and pharmacy benefits managers to avoid counting drug manufacturer copay assistance toward patients’ out-of-pocket cost obligations. Due to increased deductibles and cost-sharing requirements, patients rely on copay assistance to help them afford their prescription drugs.
See the press release

Ending Hepatitis is something we can all do every day

“To end infectious diseases, we always need more scientific advances, but it is going to take a strategic, coordinated, & resourced public health response. Fortunately, we now have national strategic plans to end several infectious diseases including viral hepatitis, HIV, & STIs. A strength included in all the plans is a reliance on taking a syndemic approach to these often intersecting epidemics. Together we can get to the finish line faster.”
See the opinion piece

Federal Government Issues Guidance to Insurers on Coverage of HIV Prevention Drugs

The federal government issued guidance to insurers to remind them of their obligation to cover pre-exposure prophylaxis (PrEP), which are drugs that prevent HIV, at no cost to their beneficiaries. The guidance, in the form of an FAQ, also clarifies that associated services with PrEP, such as provider visits and HIV, hepatitis, and STD testing along with other laboratory tests, must also be covered with no patient cost-sharing.
See the press release

Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Causes We Care About, and So Should You!

HIV

Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

Learn More

Facebook posts by @HIV+Hep

HIV and Hepatitis Policy Institute

HIV and Hepatitis Policy Institute
HIV and Hepatitis Policy Institute6 days ago

The groups filing the lawsuit noted that 17 states and Puerto Rico have passed laws requiring insurance plans to count manufacturer copay assistance toward patients’ out-of-pocket obligations.

HIV and Hepatitis Policy Institute
The groups filing the lawsuit noted that 17 states and Puerto Rico have passed laws requiring insurance plans to count manufacturer copay assistance toward patients’ out-of-pocket obligations.
   View on Facebook
HIV and Hepatitis Policy Institute
HIV and Hepatitis Policy Institute6 days ago

@HIVHep’s Carl Schmid writes in @Newsweek: “Some in #Congress seem set on slashing spending. That means domestic #HIV $$ could be on the chopping block. That’s a tragedy—one that could jeopardize our progress...

HIV and Hepatitis Policy Institute
2    View on Facebook
HIV and Hepatitis Policy Institute
HIV and Hepatitis Policy Institute1 week ago

The HIV and Hepatitis Policy Institute’s Carl Schmid in the Washington Blade: “Our investments in #HIV prevention are providing some positive results, but the persistent high # of new diagnoses & low usage of #PrEP among communities most impacted...

HIV and Hepatitis Policy Institute
   View on Facebook
HIV and Hepatitis Policy Institute
HIV and Hepatitis Policy Institute1 week ago

In POLITICO, the HIV and Hepatitis Policy Institute’s Carl Schmid warns against potential cuts to public health funding for #HIV in any potential debt ceiling deal: “This will result in new infections, more people living w/HIV & the need to provide lifetime...

HIV and Hepatitis Policy Institute
Debt ceiling talks and court battles risk also cutting off public health funding and PrEP drug access.
   View on Facebook
HIV and Hepatitis Policy Institute
HIV and Hepatitis Policy Institute1 week ago

HIV and Hepatitis Policy Institute's Carl Schmid in Roll Call: “Both Presidents Trump & Biden have put forth initiatives to #endHIV w/ calls for ↑ $$ for testing, treatment, & prevention, including for #PrEP. However, it is necessary for...

HIV and Hepatitis Policy Institute
New HIV infections dropped 12 percent in 2021 compared to 2017, but public health officials warn more needs to be done.
   View on Facebook
HIV and Hepatitis Policy Institute
HIV and Hepatitis Policy Institute1 week ago

The CDC reports #HIV cases down slightly but shocking uptake in use of #PrEP--78% of eligible Whites use it, but only 11% of Blacks. Hope #Congress will address to #End HIV:

HIV and Hepatitis Policy Institute
   View on Facebook

Tweets by @HIV+Hep

·
@
View on Twitter

Pin It on Pinterest